Editorial: Dietary n-3 and n-6 fatty acids: Are there 'bad' polyunsaturated fatty acids?

Current Opinion in Clinical Nutrition and Metabolic Care

Volumn 13, Issue 2, 2010, Pages 123-124

  Deckelbaum, Richard J ^a   Calder, Philip C ^b  

^a NewYork Presbyterian Hospital   (United States)

^b UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARACHIDONIC ACID; DOCOSAHEXAENOIC ACID; ESSENTIAL FATTY ACID; ICOSAPENTAENOIC ACID; LINOLEIC ACID; LINOLENIC ACID; OMEGA 3 FATTY ACID; OMEGA 6 FATTY ACID;

ARTERIAL WALL THICKNESS; BLOOD PRESSURE REGULATION; COGNITIVE DEVELOPMENT; EDITORIAL; FAT INTAKE; HUMAN; INSULIN RESISTANCE; NOTE;

DIETARY FATS; FATTY ACIDS, OMEGA-3; FATTY ACIDS, OMEGA-6; HUMANS;

EID: 76749130663     PISSN: 13631950     EISSN: 14736519     Source Type: Journal    
DOI: 10.1097/MCO.0b013e328336696d     Document Type: Editorial

References (14)

1. Seo T, Blaner WS, Deckelbaum RJ. Omega-3 fatty acids: molecular approaches to optimal biological outcomes. Curr Opin Lipidol 2005; 16:11-18.
2. Calder PC, Yaqoob P. Understanding omega-3 polyunsaturated fatty acids. Biofactors 2009; 35:266-272.
3. Sears B. The omega Rx zone: the miracle of the new high-dose fish oil. New York, New York: Harper Collins; 2003.
4. Simopoulos AP. The importance of the omega-6/omega-3 fatty acid ratio in cardiovascular disease and other chronic diseases. Exp Biol Med (Maywood) 2008; 233:674-688.
5. Simopoulos AP, Leaf A, Salem N Jr. Essentiality of and recommended dietary intakes for omega-6 and omega-3 fatty acids. Ann Nutr Metab 1999; 43:127-130. (Pubitemid 29373691)
6. Calder PC. Polyunsaturated fatty acids and inflammatory processes: new twists in an old tale. Biochimie 2009; 91:791-795.
7. Harris WS, Mozaffarian D, Rimm E, et al. Omega-6 fatty acids and risk for cardiovascular disease: a science advisory from the American Heart Association Nutrition Subcommittee of the Council on Nutrition, Physical Activity, and Metabolism; Council on Cardiovascular Nursing; and Council on Epidemiology and Prevention. Circulation 2009; 119:902-907.
8. Serhan CN, Hong S, Lu Y. Lipid mediator informatics-lipidomics: novel pathways in mapping resolution. AAPS J 2006; 28:E284-E297.
9. Pischon T, Hankinson SE, Hotamisligil GS, et al. Habitual dietary intake of n-3 and n-6 fatty acids in relation to inflammatory markers among US men and women. Circulation 2003; 108:155-160.
10. Block RC, Harris WS, Reid KJ, et al. EPA and DHA in blood cell membranes from acute coronary syndrome patients and controls. Atherosclerosis 2008; 19:821-828.
11. HarrisWS. The omega-6/omega-3 ratio and cardiovascular disease risk: uses and abuses. Curr Atheroscler Rep 2006; 8:453-459.
12. Stanley JC, Elsom RL, Calder PC, et al. UK Food Standards Agency Workshop report: the effects of the dietary n-6:n-3 fatty acid ratio on cardiovascular health. Brit J Nutr 2007; 98:1305-1310.
13. Sarkkinen ES, Agren JJ, Ahola I, et al. Fatty acid composition of serum cholesterol esters, and erythrocyte and platelet membranes as indicators of long-term adherence to fat-modified diets. Am J Clin Nutr 1994; 59:364-370.
14. Dwyer JH, Allayee H, Dwyer KM, et al. Arachidonate 5-lipoxygenase promoter genotype, dietary arachidonic acid, and atherosclerosis. N Engl J Med 2004; 350:4-7.